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ABSTRACT
Objectives: To determine the number of Italian
obstetrical and gynaecological societies, and to
ascertain their financial transparency.
Design: Internet-based national survey and website
content analysis.
Participants: Currently active, not privately owned,
non-religious, apolitical, obstetrical and gynaecological
associations.
Methods: From October 2014 to June 2015, scientific
societies were identified using combinations of search
terms, and examining the website of the two main
Italian obstetrical and gynaecological organisations.
Individual societies’ websites were scrutinised by two
independent investigators.
Primary and secondary outcome measures:
Number of Italian obstetrical and gynaecological
associations and its variation over time; 12 information
categories defining the general characteristics of the
societies and their websites, and the financial
transparency of the associations.
Results: The initial web search yielded 56
professional obstetrical and gynaecological
associations but nine were excluded for various
reasons. Of the remaining 47 professional associations,
17 covered both obstetrics and gynaecology, four were
specialised in obstetrics, 26 in gynaecology and 46
provided continuing medical education (CME) activities.
The number of societies has quadrupled in the last
35 years, increasing at a mean rate of one additional
society per year. The headquarters of the associations
were located in the offices of a professional congress
organiser in 15 instances, and advertisements or links
to industry products were present in 12 societies’
websites. Bylaws were accessible in 32 websites. No
information was publicly available regarding competing
interests, financial statements and quantitative external
funding.
Conclusions: The number of obstetrical and
gynaecological societies is remarkably high in Italy,
particularly in the gynaecological area. Despite CME
activity provision, transparency of societies regarding
financial issues and competing interests was almost
non-existent. Policies addressing the interactions
between medical associations and industry are
available and should be implemented.
INTRODUCTION
A core mission of medical societies is dissem-
ination of scientiﬁc information.1 2 They
foster research in distinct ﬁelds of medicine,
promote medical education and develop
clinical guidelines. Authoritative medical
associations are also inﬂuential in modulat-
ing practice, counselling administrators,
advising politicians regarding public health-
care programmes and regulating professional
conduct. Thus, the social role of these orga-
nisations entails exceedingly important clin-
ical and ethical implications.1–4
However, some authors are concerned that
economic aspects are interfering with the
moral foundations of medical associations.1
In particular, a progressive imbalance has
been observed in funding derived from
membership dues and grants, and contracts
awarded by government or charitable foun-
dations, in favour of support from for-proﬁt
organisations.1 5–7 This situation may gener-
ate a conﬂict of interest (COI), which has
been deﬁned as ‘a set of circumstances that
Strengths and limitations of this study
▪ Different search strategies were adopted to iden-
tify all currently active Italian obstetrical and
gynaecological scientific societies, that is,
Internet, interviewing executive personnel of the
two main national organisations, and direct
contact with some presidents and
past-presidents.
▪ Two independent investigators retrieved informa-
tion, abstracted data on standardised forms and
conducted a website content analysis on 12
items regarding the general characteristics of the
medical associations and their websites, as well
as societies’ financial transparency.
▪ The data presented describe a selected picture of
a specific medical specialty in Italy. The findings
can neither be generalised to other medical spe-
cialties nor to other countries.
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creates a risk that professional judgment or actions
regarding a primary interest will be unduly inﬂuenced
by a secondary interest’.8 The primary interest of a scien-
tiﬁc society is to promote the highest quality of care also
through the education of its members.9 The secondary
interest is, in this case, the ﬁnancial well-being of the
society together with the ﬁnancial proﬁt of some com-
mercial entities. A COI may occur not only if a profes-
sional medical organisation (professional medical
association, PMA) receives money from manufacturers
of drugs or devices used in the same medical area of
interest as the society, but also when individual ofﬁcers
of the organisation have personal ﬁnancial ties to indus-
tries that could inﬂuence their actions and decisions
within the PMA. Of note, COI is a condition, not a
behaviour. In other words, when a COI exists, no actual
unethical conduct has necessarily arisen.5 However,
although COI and bias are not synonymous, the former
is a demonstrated risk factor for the latter.10
Two different approaches have been suggested to deal
with COIs of PMAs, that is, a divestment strategy (pro-
gressively discontinuing commercial support) and a man-
agement strategy (disclosing COIs and adopting rules to
limit their potentially pernicious effects).5 9 As the oper-
ating budget of many PMAs is substantially based on
industry funding, the latter policy has generally been
preferred, purportedly to ensure stability in organisation
functioning and to avoid curtailments in services to
members.1 5–7 11 To be efﬁcient, any strategy to ‘manage’
COIs about interactions with industry, should be based
on thorough ﬁnancial transparency, particularly, but not
exclusively, regarding commercial support of annual
meetings. In fact, most PMAs base their ﬁnancial sustain-
ability on revenues from periodic congresses, as in these
occasions industry generally purchases exhibit hall space,
sponsors conference sessions or satellite symposia, pays
the registration fee for a variable number of attendees
and buys advertising opportunities.2 9 12 13
Further complicating the above scenario, the past
decades have witnessed a tendency towards proliferation
of medical societies focused on subspecialty areas or
even single diseases, paralleling the general trend of
modern medicine in the direction of over-
specialisation.14 The intrinsic beneﬁt of creating small
and subspecialty associations is the possibility of increas-
ing knowledge on speciﬁc disorders. However, compared
with major national and international organisations,
small societies may have less impact regarding public
advocacy, information of healthcare decision makers and
deﬁnition of public health system strategies. Moreover,
small societies generally have restricted ﬁnancial
resources, thus their possibility to fund research seems
limited. In this regard, the proliferation of subspecialty
medical associations could also be viewed as a potential
waste of precious resources that could be invested more
efﬁciently in the interest of patients.
In addition, the quality of the information dissemi-
nated by scientiﬁc organisations should be scrutinised
with care. Intellectual independence is essential, espe-
cially when providing continuing medical education
(CME) activity,10 15–17 but fragmentation and subspeciali-
sation may expose medical societies to increased ﬁnan-
cial vulnerability and, hypothetically, this could result in
an increase in the risk of undue inﬂuence of pharma-
ceutical, biotechnology and device industries.
Noteworthy, the percentage of the overall national
funding for CME activities provided by industry is par-
ticularly high in Italy, with reported ﬁgures varying from
60%18 to almost 100%19 of the total expenditure.
The phenomenon of proliferation of professional
organisations appears to be particularly intense in the
gynaecological ﬁeld, probably owing to the multitude of
issues regarding women’s health. Therefore, we decided
to conduct a survey in order to examine the condition
of obstetrical and gynaecological societies in Italy. The
primary objectives were to determine the overall
number of associations and to verify whether a trend
exists towards an increase in the number of subspecialty
organisations over time. Secondary aims were to ascer-
tain the societies’ level of transparency regarding
general competing interests and funding from industry,
and to evaluate if a relation exists between the provision
of CME activity and the degree of ﬁnancial transparency.
METHODS
This survey was conducted by retrieving and analysing
information from the internet. As publicly available data
were used, the present study was exempt from the Ethics
Committee’s approval. The study was restricted to profes-
sional organisations active during 2014 in Italy. Websites
were identiﬁed using ‘Google’, consistently ranked as
the most popular search engine (http://www.google.
com).20 The following Italian search terms and phrases
were used: ‘Italian obstetrical and gynaecological soci-
eties’, ‘obstetrical and gynaecological societies AND
Italy’, ‘ Italian obstetrical and gynaecological associa-
tions’, ‘obstetrical and gynaecological associations AND
Italy’, ‘Italian obstetrical and gynaecological federations’,
‘obstetrical and gynaecological federations AND Italy’,
‘Italian obstetrical and gynaecological organisations’ and
‘obstetrical and gynaecological organisations AND Italy’.
In addition, the websites of the two major national
obstetrical and gynaecological societies (Società Italiana
di Ginecologia e Ostetricia, SIGO; Associazione Ostetrici
Ginecologi Ospedalieri Italiani, AOGOI) were examined
with the objective of identifying all the subspecialty orga-
nisations in the ﬁeld afﬁliated to SIGO and AOGOI. All
the authors independently conducted the initial search
from 31 October to 7 November 2014. After completion
of the list of associations, these were categorised, based
on their name, into combined obstetrical and gynaeco-
logical, obstetrical only and gynaecological only
organisations.
Individual societies’ websites were then independently
scrutinised from 8 November to 12 December 2014, and
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from 15 to 19 June 2015, by two authors (PVe and
MPF), in order to verify the correctness of the initial cat-
egorisation, and to ascertain whether the association was
public (ie, not privately owned by single individuals),
and with a deﬁned mission and a regular board, includ-
ing a president, a treasurer, a secretary and an executive
committee. Individual or privately owned organisations,
those not speciﬁcally aimed at physicians and those with
a religious or political proﬁle, were excluded. Moreover,
information was collected on standardised abstraction
forms on 12 items deﬁning two domains, those being,
(1) the general characteristics of the society and its
website (year of establishment; whether the headquar-
ters were independent or located in the ofﬁces of a pro-
fessional congress organiser and accredited CME
provider; online availability of the society’s bylaws; provi-
sion of CME activity; inclusion of sponsored sessions or
symposia in the society’s last annual meeting pro-
gramme; presence on the society’s website of industry
advertisement or links to industries’ websites) and (2)
the ﬁnancial transparency of the association (discussion
of ﬁnancial COIs in the society’s bylaws; adoption of a
policy for interactions with industry; availability of ﬁnan-
cial COI disclosures of the presidential trio (president,
past president and president-elect), board members and
executive staff; online availability of annual ﬁnancial
statement; disclosure of restricted and unrestricted
industry grants and individual donations; and indication
of industry sponsorship in the last annual meeting pro-
gramme based on informative printed text in addition
to mere logo inclusion).
In cases where the information on a PMA’s year of
establishment was missing, the executive staff members
of the above two major national obstetrical and gynaeco-
logical societies were consulted by email and telephone.
Moreover, PVe directly contacted the presidents and
selected board members of some associations in order
to obtain missing data from original documents. A ﬁnal
extraction form was compiled from the two separate
evaluation forms, with correction or resolution of any
discrepancies between abstractors by consensus reached
after discussion or further joint re-examination of
selected societies’ websites.
In addition, two authors independently used the
Health on the Net Foundation Code of Conduct21 for
medical websites, with the objective of examining the
degree of transparency of the healthcare information
provided on the websites of the two major national
obstetrical and gynaecological associations, SIGO and
AOGOI. The HONcode is an instrument developed to
assess the intent of a website to publish accurate infor-
mation, and it includes items on transparency, ﬁnancial
disclosure and advertising policy.21
RESULTS
The initial web search yielded 56 professional obstetrical
and gynaecological associations, but two were
immediately excluded because they were known to be
privately owned (Società Italiana Studi di Medicina della
Riproduzione, SISMeR) or individually managed
(Fondazione Graziottin per la Cura del Dolore nella
Donna). Examination of societies’ websites resulted in
the exclusion of three organisations with deﬁned socio-
political or religious characteristics (Associazione
Italiana Ginecologi Ostetrici Cattolici, AICOG; Società
Italiana Procreazione Responsabile, SIPRe; Libera
Associazione Italiana Ginecologi per l’Applicazione
della Legge 194/78, LAIGA). One association
(Confederazione Italiana Ginecologi Ospedalieri,
CIGO) was excluded because its activities were unclear
and not typical of a regular scientiﬁc society (eg, organ-
isation of conferences and development of clinical
recommendations). Another association was apparently
no longer currently active (Società Italiana di
Endoscopia e Laserterapia in Ginecologia, SIELG). Only
one reviewer excluded two other organisations. Joint
re-examination of the two websites demonstrated that
the activity of one association (Fondazione Confalonieri
Ragonese) was limited to drafting clinical practice
recommendations on behalf of AOGOI, whereas the
activity of the other (Associazione Italiana di Ostetricia,
AIO) was aimed mainly at midwives rather than at physi-
cians. A shared decision was taken to exclude the latter
two organisations.
Summary characteristics of the remaining 47 profes-
sional associations are shown in table 1. Individual soci-
eties’ details regarding the general characteristics of the
associations and their websites as well as PMAs’ ﬁnancial
transparency are included in online supplementary
table S1.
A total of 24 organisations were afﬁliated with SIGO
(http://www.sigo.it/societa-afﬁliate/) and 6 with AOGOI
(http://www.aogoi.it/opencms/sezioniOriz/
societaAfﬁliate/index.html). Seventeen ‘generalist’ asso-
ciations covered both obstetrics and gynaecology (the 2
main ones plus 15 minor societies), 4 were specialised in
obstetrical areas only and 26 were specialised in gynaeco-
logical areas only. In this latter group, seven organisa-
tions dealt with infertility, four with pelvic and
endoscopic surgery, four with urogynaecology and two
with, respectively, cervical pathology, and contraception
and climacteric. After exclusion of the 17 ‘generalist’
organisations, the distribution of societies’ main area of
interest was substantially skewed towards gynaecology
(26/30; 87%).
Six societies did not appear to have a website. In 12
cases, including those in which a website could not be
found, the year of establishment of the association was
obtained from SIGO or AOGOI executive personnel,
and from direct contact between PVe and presidents
or past-presidents. In the period 1980–2014, the
number of Italian obstetrical and gynaecological soci-
eties has quadrupled, starting from 12 and increasing
at a mean rate of one society per year over the last
35 years (ﬁgure 1).
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Table 1 General characteristics and financial transparency of Italian professional obstetrical and gynaecological associations extracted from their websites
Clinical and
research
area
Number
with
website
Headquarters
located in the
offices of a
professional
congress
organiser
Society
bylaws
posted
on
website
CME
activity*
Sponsored
session/
symposia
included in
the PMA’s
last annual
meeting
programme
Industry
advertisement
on society’s
website or
links to
industries’
websites
Financial
COI issue
discussed
in bylaws
Policy for
interaction
with
industry
available
online†
Financial
COIs of
presidents,
board
members
and
executive
staff
disclosed
on website
Annual
financial
statement
available
online
Disclosure
of financial
support
(industry
grants and
individual
donations)
available
online
Industry
sponsorship
indicated in
the PMA’s
last annual
meeting
programme
Obstetrics
and
gynaecology
(n=17)
14 7 12 17 4 8 0 0 0 0 0 8
Obstetrics
only (n=4)
4 1 2 4 0 0 0 0 0 0 0 0
Gynaecology
only (n=26)
23 7 18 25 5 4 0 0 0 1 0 7
Data are numbers.
*When an association’s website was not found or when the information was not indicated on website, CME activity was identified scrutinising the online programmes of the society’s conferences
and courses.
†Specific directives regulating professional obstetrical and gynaecological associations’ conduct in case of private/commercial financial support.
CME, continuing medical education; COI, conflict of interest; PMA, professional medical association.
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The headquarters of the associations were independ-
ent in 26/41 instances, and located in the ofﬁces of a
professional congress organiser and accredited CME
provider in the remaining 15. Societies’ bylaws were pub-
lished online for 32/41 (78%) of the identiﬁed websites.
Forty-six associations organised conferences and pro-
vided CME activities. When an ofﬁcial society’s website
was not identiﬁed or when the information was not indi-
cated on its website, CME activity was veriﬁed by scruti-
nising the online programmes of the society’s
conferences and courses. A total of 9/46 associations
included sponsored sessions or symposia in their last
annual meeting programme. Advertisements or links to
industry products were present on 12/41 societies’ web-
sites (8 in the obstetrical and gynaecological subgroup
and 4 in the gynaecological only subgroup).
With regard to ﬁnancial transparency, in none of the
32 developed bylaws was the issue of COIs mentioned.
No association had apparently developed a policy for
interactions with industry. A total of 423 board members
were identiﬁed, including the presidential trios, treas-
urers and secretaries. Forty-eight members were
included at the same time on the board of two distinct
organisations, 14 members on the board of three organi-
sations and ﬁve on the board of four organisations. The
competing interest disclosures of board members and
executive staff were never posted on societies’ websites.
The annual ﬁnancial statement was published online
in only one case and, with this exception, no informa-
tion was publicly available on any other website regard-
ing the society’s source of ﬁnancial support, as no data
was accessible on restricted and unrestricted industry
grants or individual donations, nor on industry sponsor-
ship for the last annual meetings, courses or other edu-
cational events.
Evaluation of transparency of SIGO and AOGOI web-
sites according to the HONcode principles21 identiﬁed
lack of information (see online supplementary table S2).
In particular, neither website attributed speciﬁc health/
medical information to an author; the sources of the
funding for both sites were not clearly described; adver-
tising was not always identiﬁed as such; and the sites
were part of a link/banner exchange but there was no
speciﬁc description about the site advertising policy.
Moreover, the SIGO website did not provide the last
modiﬁcation date, and made claims relating to the
beneﬁt or performance of a speciﬁc medical treatment,
commercial product or service based on the author’s
personal research or opinion.
Both websites provided free CME e-learning courses
supported by pharmaceutical industries manufacturing
drugs or commercial products used speciﬁcally in those
medical areas on which the courses were focused.
Finally, the SIGO website included descriptions of some
campaigns supported by industries with direct or indir-
ect interests in related medical ﬁelds.
DISCUSSION
The results of the present survey on Italian obstetrical
and gynaecological societies and content analysis of
their websites depict an academic scenario that warrants
consideration. Remarkably large numbers of organisa-
tions were identiﬁed, characterised by a progressive and
impressive increase over time, especially during the last
decades. We do not have a clear explanation for this
phenomenon. According to the list of member societies
of the Federazione delle Società Medico-Scientiﬁche
Italiane (Italian Federation of Medical-Scientiﬁc
Societies, FISM), which includes Italian medical and sci-
entiﬁc societies involved in medical education or
research activities of national interest, this situation does
not seem to be generalisable to other medical special-
ties.22 Of note, the gynaecological subgroup was charac-
terised by several replications, particularly in the fertility
and sterility, pelvic and endoscopic surgery, and urogy-
naecology areas. The reason for these duplications is not
readily understandable.
Figure 1 Variation in the
number of Italian obstetrical and
gynaecological societies over
time. The number on top of each
column is the number of
societies.
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The observed disproportion in the distribution of sub-
specialty associations decidedly cannot be explained by
unequal distribution of the clinical content of the two
main areas of the addressed specialty—obstetrics and
gynaecology. Thus, it could be hypothesised that Italian
gynaecologists were more scientiﬁcally proactive com-
pared with their obstetrical colleagues, but we could not
ﬁnd evidence to support this interpretation. An alterna-
tive theoretical explanation of this observation is that
commercial sponsorship skewed the topics in favour of
disorders from which a larger proﬁt could be made. In
this regard, gynaecology might prove a more lucrative
medical area compared with obstetrics, at least in terms
of markets for several costly new drugs, surgical devices
and diagnostic tools. However, we have no data to
support this hypothesis.
Financial transparency of the organisations included
was almost non-existent, as we were unable to retrieve
relevant, publicly available information, with the excep-
tion of the annual ﬁnancial statement of a single, small
gynaecological association. Six associations did not
appear to have a website, thus providing no publicly
available information. Unfortunately, online publishing
of annual budgets and data regarding ﬁnancial support
is not a legal requirement for Italian scientiﬁc societies,
and we could not identify alternative sources of informa-
tion. We could not verify if and to what extent ﬁnancial
relations were in place between Italian obstetrical and
gynaecological associations and industry, and we are
unable to reject the hypothesis that they did not exist.
This also applies to commercial support of annual meet-
ings and educational events, although in this case, the
obstetrical and gynaecological area would constitute an
exception with respect to data on overall industry
funding of Italian CME activities.18 19
We used websites as the main source of information
regarding a society’s ﬁnancial transparency. It could be
argued that websites can be useful to identify national
PMAs, but they provide no accurate speciﬁc informa-
tion on COIs and commercial funding. This constitutes
a limitation of our study, as we could have sent a ques-
tionnaire directly to individual medical organisations or
interviewed the president and executive ofﬁcers.
However, the aim of our survey was to verify whether
information regarding COIs of board members and
industry support of Italian gynaecological societies was
easily and publicly accessible, which, nowadays, means
posted on a society’s website.17 The concept of trans-
parency should not imply the need for individual inves-
tigation into a society’s board members or executive
staff by doctors and citizens to acquire this type of
information.
Almost all the identiﬁed societies provided CME activ-
ity through conferences and courses. Lack of disclosure
regarding industry support for scientiﬁc events involving
CME activity (or lack of a website) in societies’ websites
is neither surprising nor unlawful, but raises ethical con-
cerns. Some relevant information can be retrieved from
the website of the Agenzia Nazionale per i Servizi
Sanitari Regionali (Age.na.s), which manages the
national CME programme on behalf of the Italian
Ministry of Health. However, although the industries
sponsoring the events are listed, the ﬁnancial support is
expressed as a relative percentage of an overall budget
that is not quantiﬁed (http://ecm.agenas.it/BancaDati/
SB_Lista_Cerca_Accr.asp; accessed on 23 March 2015).
Independently of legal requirements, we believe that
scientiﬁc societies should provide data on industry
support of CME activity spontaneously, and should post
it on their websites. This seems particularly important
when the organisations delivering CME activity, which is
a source of income for the provider, do not have inde-
pendent headquarters, but are hosted by professional
congress organisers who may receive money also from
pharmaceutical companies and manufacturers of
medical devices,23 24 or when advertisements or links to
industry products are included in their websites.
However, without a formal evaluation of CME ‘products’
(ie, scientiﬁc quality and compliance with society
mandate), no conclusions can be drawn.
Competing interests of members of the boards and
executive committees of a society were also not dis-
closed, and this appears somewhat concerning.1 5 9 In
general, ﬁnding experts without competing interests is
difﬁcult, and, ideally, they would all be concentrated in
the boards of a few major obstetrical and gynaecological
societies. The multiplication of boards and committees
needed as a consequence of the proliferation of smaller
organisations, particularly in the gynaecological area,
implies that most of their directors and executives will
have COIs, simply because there are not sufﬁcient
experts without COIs to cover all the available positions.
This may have implications regarding a society’s activ-
ities, including the development of practice guidelines.25
This issue would be greater if members with COIs serve
on the board of more than one association.
Taking a selected picture of a speciﬁc country is a
limit of our study that impedes generalisation of the
ﬁndings. However, we considered that this survey
allowed us to deﬁne a general scheme to be adopted for
an investigation of this type, identifying reasonable end
points and speciﬁc information categories. We are not
aware of similar surveys published in the scientiﬁc litera-
ture, and believe that this scheme could also be used to
investigate the condition of PMAs in different specialties
and in different countries.
Rothman and coworkers described in detail the many
potential threats to PMAs’ integrity, identiﬁed speciﬁc
COIs that may affect the organisations’ activity, and for-
mulated guidelines to prevent undue industry inﬂuence
aimed at divestment from commercial support rather
than management of ﬁnancial competing interests.2 In
fact, the authors maintain that “PMAs should work
toward a complete ban on pharmaceutical and medical
device industry funding ($0), except for income from
journal advertising and exhibit hall fees.”2
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The Council of Medical Specialty Societies was created
in the USA in 1965, with the objective of providing an
independent forum for cross-specialty collaboration in
order to inﬂuence policy on issues with a nationwide
scope, such as medical education and accreditation. The
Council has issued a code for interactions with compan-
ies that includes seven core principles covering COI,
ﬁnancial disclosure, independent programme develop-
ment and independent leadership.26 With regard to
transparency, the code states that ‘Societies will make
their conﬂict of interest policies and/or forms available
to their members and the public’, and ‘Societies will dis-
close company support (at a minimum, educational
grants, corporate sponsorships, charitable contributions
and support of research grants), making this informa-
tion available to their members and the public’, and
‘Societies will disclose all ﬁnancial and uncompensated
relationships that key society leaders and members of
the board of directors of the society’ membership organ-
ization have with companies, making this information
available to their members and the public’.26 Up to now,
the code has been signed by 32 North-American
member societies of the Council and by 17
North-American non-member societies.27
Examples already exist of PMAs disclosing on their
website the breakdown of industry contribution towards
the consolidated revenue of the society, as well as disclos-
ure statements reported by each member of the board
of directors,28 and publishing—in meeting programmes
—the company from which payment is received, the
amount of payment by categories, and the speciﬁc type
of relationship held with the company.29 A policy on
rigorous control over COIs has been implemented by
several medical and surgical scientiﬁc societies,19 28–34 in
some cases without detrimental consequences in terms
of ﬁnances, membership, attendance at annual meetings
or leadership recruitment.29 31 32
It is currently unclear if the observed progressive
growth in the number of gynaecological associations,
together with the relative congresses and courses, does
more good than harm to patients.35 Future research
should aim at verifying whether this phenomenon
results exclusively in enhanced knowledge and translates
into better care of women’s health, or if it facilitates the
dissemination of partly biased information within the sci-
entiﬁc community.
Italian scientists should lobby for transparency of
public disclosure of COIs of societies providing CME
activity and on implementation of efﬁcient societies’ pol-
icies for interactions with industry. Moreover, the
Ministry of Health should only grant CME credits to con-
ferences and educational events, provided that attendees
are fully and publicly aware of ﬁnancial connections
between the scientiﬁc society and any industry involved,
including quantitative information regarding funding
for the meetings.36–38 More in general, a sort of
Sunshine Act 39 focused on scientiﬁc societies and edu-
cational activity, in addition to that aimed at individual
doctors, and with potential application to multiple set-
tings and jurisdictions, could prove of great beneﬁt for
patients, practising physicians and clinical investigators.
A complete lack of transparency on the above issues
nowadays appears hardly justiﬁable and ethically ques-
tionable. Indeed, COIs of PMAs might be considered
more serious than those of individuals, because, where
distorted information is disseminated at educational
events, the effect would be multiplied with potential sub-
stantial consequences on prescribing practices of many
of the society’s members.3–5 Moreover, the deﬁnition of
‘COI’ itself, in the case of PMAs, may be somewhat mis-
leading, as it has been pointed out that a medical orga-
nisation’s commitment to patients and public health is a
moral duty and not a mere interest.5
Collaboration between PMAs, and research and devel-
opment departments of pharmacological companies
and medical devices manufacturers, is very important
for the advancement of medicine. This form of inter-
action is welcome in the interest of patients and society.
On the contrary, collaboration between PMAs and
company marketing departments on CME events and
society annual meetings may blur the distinction
between the interest of the PMA, which is education,
and that of industry, which is selling products.
Despite individual or organisational COIs, the ofﬁcers
of many medical associations may well be disinterested
and passionate, and provide valuable activities for the
beneﬁt of society members. However, members of PMAs
are not the end users of drugs and devices marketed by
industry; rather, they are the gatekeepers entrusted to
make evidence-based recommendations to the real end
user, that is, the patient.9 When the citizens eventually
have to pay the bill, either directly or indirectly through
national health systems, the conduct of PMAs may not
be only based on the presumed good faith of their ofﬁ-
cers, but should contemplate the provision of publicly
available and easily accessible data on ﬁnancial compet-
ing interests. Transparency and disclosures do not elim-
inate COIs,40 41 but may enable doctors and lay people
to contextualise the scientiﬁc information disseminated
in various ways by medical organisations, putting it in
the right perspective.
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